ARCH Venture Partners VII, L.P., 10% Owner at Syros Pharmaceuticals, Inc. (SYRS), sold 123,300 shares at $7.81 ($957K) on 2019-07-16, disclosed to the SEC on 2019-07-17.
Open-market sale of $957k SYRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.27 | 2,700 | $22K | 2.3% |
| 2 | $7.81 | 25,779 | $201K | 21.0% |
| 3 | $7.81 | 25,779 | $201K | 21.0% |
| 4 | $7.70 | 34,521 | $266K | 27.8% |
| 5 | $7.70 | 34,521 | $266K | 27.8% |
| Total | $7.76 avg | 123,300 |
| $957K |
| 100% |
| Filing → |